RecruitingNot ApplicableNCT07580755

Mesenchymal Stem Cells in the Treatment of Burn Wounds

A Randomized Controlled Study on the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Extensive Burns


Sponsor

The First Affiliated Hospital of Xinxiang Medical College

Enrollment

90 participants

Start Date

Apr 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Burn patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), and received the same treatment under the same conditions simultaneously.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying high-dose stem cell gel group, low-dose stem cell gel group, and others for people with burn injury and burn patients. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTlow-dose stem cell gel group

Using hydrogels containing low-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting

COMBINATION_PRODUCThigh-dose stem cell gel group

Using hydrogels containing or without differenthigh-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting

OTHERwith only the gel

Using only hydrogels as wound dressings to promote wound healing in burn patients after thick skin grafting


Locations(1)

The First Affiliated Hospital of Xinxiang Medical College

Xinxiang, Henan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07580755


Related Trials